--2025/Q1-- / 13.461M--
--2024/Q4-- / 15.551M--
Nov 5, 20242024/Q314.269M / 14.132M--
--2024/Q211.772M / 13.047M--
--2024/Q17.410M / 14.664M--
US Stock MarketDetailed Quotes
BEAM Beam Therapeutics
- 30.200
- +2.685+9.76%
Close Dec 10 16:00 ET
- 30.190
- -0.010-0.03%
Pre 08:30 ET
2.50BMarket Cap-19.11P/E (TTM)
31.000High27.600Low2.30MVolume27.730Open27.515Pre Close67.99MTurnover3.35%Turnover RatioLossP/E (Static)82.81MShares49.50052wk High3.16P/B2.07BFloat Cap20.84052wk Low--Dividend TTM68.63MShs Float138.522Historical High--Div YieldTTM12.36%Amplitude13.000Historical Low29.537Avg Price1Lot Size
Beam Therapeutics Key Stats
Beam Therapeutics Q3 2024 Earnings Date
Currency：USDNov 5, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 14.13M | 14.27M | +137.03K |
| Beat Est. | -17.80% | -17.01% | +0.97% |
| EPS | -1.15 | -1.17 | -0.02 |
| Miss Est. | +6.12% | +4.10% | -2.17% |
Analyst Rating
Dec 10, 2024
Beam Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Beam Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data
